Astera Labs (ALAB)

Technology · Semiconductors
$371.44 -4.71% on the day Market cap $66.1B 52-week range $97.89 to $499.48 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
38% a year for 10 years

At a market value of $66.1B, Astera Labs's free cash flow of $282M (fiscal 2025) would need to grow about 38% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 1 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Astera Labs's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price38.5% a year
Free cash flow, last 1 years175.1% a year
Revenue, same period120.2% a year
Price to free cash flow234.6x

Fundamental grade

B

Five factors scored 1 to 9 from ALAB's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation1
Profitability8
Growth9
Financial health9
Cash efficiency9

Key numbers

P/E (trailing)258.8x
P/E (forward)112.0x
Price / free cash flow234.6x
EV / EBITDA141.7x
Price / sales55.0x
Price / book38.0x
Revenue growth+104.5%
Operating margin22.8%
Net margin30.7%
Return on equity21.4%
Dividend yield—
Debt / equity0.12x

Results from SEC filings

Fiscal years, from Astera Labs's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year2022202320242025
Revenue$80M$116M$396M$853M
Net income-$58M-$26M-$83M$219M
Free cash flow-$40M-$15M$102M$282M
EPS (diluted)-$1.71-$0.71-$0.64$1.22
Operating margin-75.4%-25.5%-29.3%20.3%

Where the revenue comes from

Revenue by products, fiscal 2024.

Product sales$393M99%
Engineering services$3M1%

Superinvestors who own ALAB

From each investor's latest 13F filing (what a 13F shows). 4 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Lee Ainslie
Maverick Capital
Added $515M4.6%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed $32M0.01%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added $14M0.03%Q2 2026
Hersh Cohen
ClearBridge Investments
New position $4M0.00%Q2 2026

Insider buying

Open-market purchases by Astera Labs's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of ALAB in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when ALAB trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Astera Labs's stock price imply?

At a market value of $66.1B, Astera Labs would need its free cash flow to grow about 38% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 1 years its free cash flow grew 175% a year.

Are Astera Labs insiders buying the stock?

No open-market insider purchases of ALAB in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Astera Labs?

4 of the superinvestors Investingly tracks hold ALAB in their latest 13F, including Lee Ainslie, Cliff Asness, Joel Greenblatt.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.